FDA warns about safety risks of tailored weight-loss drugs
(Reuters) – The U.S. Food and Drug Administration (FDA) warned about the safety risks of using compounded or custom-made versions of popular weight-loss drugs such as Wegovy and diabetes drug Ozempic. The…
